138 related articles for article (PubMed ID: 37628841)
21. p16(INK4a) promoter methylation and protein expression in breast fibroadenoma and carcinoma.
Di Vinci A; Perdelli L; Banelli B; Salvi S; Casciano I; Gelvi I; Allemanni G; Margallo E; Gatteschi B; Romani M
Int J Cancer; 2005 Apr; 114(3):414-21. PubMed ID: 15578730
[TBL] [Abstract][Full Text] [Related]
22. DNA Methylation Profiling of Breast Cancer Cell Lines along the Epithelial Mesenchymal Spectrum-Implications for the Choice of Circulating Tumour DNA Methylation Markers.
Le AV; Szaumkessel M; Tan TZ; Thiery JP; Thompson EW; Dobrovic A
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30154364
[TBL] [Abstract][Full Text] [Related]
23. Comparison study of MS-HRM and pyrosequencing techniques for quantification of APC and CDKN2A gene methylation.
Migheli F; Stoccoro A; Coppedè F; Wan Omar WA; Failli A; Consolini R; Seccia M; Spisni R; Miccoli P; Mathers JC; Migliore L
PLoS One; 2013; 8(1):e52501. PubMed ID: 23326336
[TBL] [Abstract][Full Text] [Related]
24. Aberrant DNA methylation of cancer-related genes in giant breast fibroadenoma: a case report.
Marzese DM; Gago FE; Orozco JI; Tello OM; Roqué M; Vargas-Roig LM
J Med Case Rep; 2011 Oct; 5():516. PubMed ID: 22011321
[TBL] [Abstract][Full Text] [Related]
25. Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation.
Wojdacz TK; Dobrovic A
Nucleic Acids Res; 2007; 35(6):e41. PubMed ID: 17289753
[TBL] [Abstract][Full Text] [Related]
26. Rapid determination of AKAP12 promoter methylation levels in peripheral blood using methylation-sensitive high resolution melting (MS-HRM) analysis: application in colorectal cancer.
Liu W; Guan M; Su B; Li J; Ma W; Liu C; Li M; Lin Y; Lu Y
Clin Chim Acta; 2010 Jul; 411(13-14):940-6. PubMed ID: 20227403
[TBL] [Abstract][Full Text] [Related]
27. Methylation of cystatin M promoter is associated with unfavorable prognosis in operable breast cancer.
Kioulafa M; Balkouranidou I; Sotiropoulou G; Kaklamanis L; Mavroudis D; Georgoulias V; Lianidou ES
Int J Cancer; 2009 Dec; 125(12):2887-92. PubMed ID: 19551853
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of protein expression and DNA methylation profiles detected by pyrosequencing in invasive breast cancer.
Zmetakova I; Danihel L; Smolkova B; Mego M; Kajabova V; Krivulcik T; Rusnak I; Rychly B; Danis D; Repiska V; Blasko P; Karaba M; Benca J; Pechan J; Fridrichova I
Neoplasma; 2013; 60(6):635-46. PubMed ID: 23906298
[TBL] [Abstract][Full Text] [Related]
29. Cell-free and cell-bound circulating DNA in breast tumours: DNA quantification and analysis of tumour-related gene methylation.
Skvortsova TE; Rykova EY; Tamkovich SN; Bryzgunova OE; Starikov AV; Kuznetsova NP; Vlassov VV; Laktionov PP
Br J Cancer; 2006 May; 94(10):1492-5. PubMed ID: 16641902
[TBL] [Abstract][Full Text] [Related]
30. Discovery and validation of DNA hypomethylation biomarkers for liver cancer using HRM-specific probes.
Stefanska B; Bouzelmat A; Huang J; Suderman M; Hallett M; Han ZG; Al-Mahtab M; Akbar SM; Khan WA; Raqib R; Szyf M
PLoS One; 2013; 8(8):e68439. PubMed ID: 23950870
[TBL] [Abstract][Full Text] [Related]
31. MGMT promoter methylation determined by HRM in comparison to MSP and pyrosequencing for predicting high-grade glioma response.
Switzeny OJ; Christmann M; Renovanz M; Giese A; Sommer C; Kaina B
Clin Epigenetics; 2016; 8():49. PubMed ID: 27158275
[TBL] [Abstract][Full Text] [Related]
32. Association of aberrant DNA methylation with clinicopathological features in breast cancer.
Tserga A; Michalopoulos NV; Levidou G; Korkolopoulou P; Zografos G; Patsouris E; Saetta AA
Oncol Rep; 2012 May; 27(5):1630-8. PubMed ID: 22159596
[TBL] [Abstract][Full Text] [Related]
33. ASSESSMENT OF THE VALUE OF METHYLATION FEATURES IN DIFFERENT TISSUES FOR PREOPERATIVE IDENTIFICATION OF HIGH-RISK BREAST TUMORS.
Kankava K; Kvaratskhelia E; Burkadze G; Tsikhiseli G; Azanishvili T; Tkemaladze T; Abzianidze E
Georgian Med News; 2019 Apr; (289):143-151. PubMed ID: 31215897
[TBL] [Abstract][Full Text] [Related]
34. Variability in the measurement of the methylation status of lung cancer-related genes in bronchial secretions.
Millares L; Rosell A; Setó L; Sanz J; Andreo F; Monsó E
Oncol Rep; 2014 Oct; 32(4):1435-40. PubMed ID: 25069886
[TBL] [Abstract][Full Text] [Related]
35. The influence of DNA degradation in formalin-fixed, paraffin-embedded (FFPE) tissue on locus-specific methylation assessment by MS-HRM.
Daugaard I; Kjeldsen TE; Hager H; Hansen LL; Wojdacz TK
Exp Mol Pathol; 2015 Dec; 99(3):632-40. PubMed ID: 26551081
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic values of GHSR DNA methylation pattern in breast cancer.
Botla SK; Gholami AM; Malekpour M; Moskalev EA; Fallah M; Jandaghi P; Aghajani A; Bondar IS; Omranipour R; Malekpour F; Mohajeri A; Babadi AJ; Sahin Ö; Bubnov VV; Najmabadi H; Hoheisel JD; Riazalhosseini Y
Breast Cancer Res Treat; 2012 Oct; 135(3):705-13. PubMed ID: 22899222
[TBL] [Abstract][Full Text] [Related]
37. Methylation of the hTERT promoter: a novel cancer biomarker for leptomeningeal metastasis detection in cerebrospinal fluids.
Bougel S; Lhermitte B; Gallagher G; de Flaugergues JC; Janzer RC; Benhattar J
Clin Cancer Res; 2013 Apr; 19(8):2216-23. PubMed ID: 23444211
[TBL] [Abstract][Full Text] [Related]
38. MS-HRM protocol: a simple and low-cost approach for technical validation of next-generation methylation sequencing data.
Javadmanesh A; Mojtabanezhad Shariatpanahi A; Shams Davodly E; Azghandi M; Yassi M; Heidari M; Kerachian M; Kerachian MA
Mol Genet Genomics; 2022 Jul; 297(4):1101-1109. PubMed ID: 35616708
[TBL] [Abstract][Full Text] [Related]
39. Hypermethylation of calcitonin gene regulatory sequences in human breast cancer as revealed by genomic sequencing.
Hakkarainen M; Wahlfors J; Myöhänen S; Hiltunen MO; Eskelinen M; Johansson R; Jänne J
Int J Cancer; 1996 Dec; 69(6):471-4. PubMed ID: 8980249
[TBL] [Abstract][Full Text] [Related]
40. [Breast cancer diagnostics based on extracellular DNA and RNA circulating in blood].
Rykova EIu; Skvortsova TE; Hoffmann AL; Tamkovich SN; Starikov AV; Bryzgunova OE; Permiakova VI; Warnecke JM; Sczakiel G; Vlasov VV; Laktionov PP
Biomed Khim; 2008; 54(1):94-103. PubMed ID: 18421914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
